1. Home
  2. ZKH vs TBPH Comparison

ZKH vs TBPH Comparison

Compare ZKH & TBPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ZKH
  • TBPH
  • Stock Information
  • Founded
  • ZKH 1998
  • TBPH 2013
  • Country
  • ZKH China
  • TBPH United States
  • Employees
  • ZKH N/A
  • TBPH N/A
  • Industry
  • ZKH
  • TBPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • ZKH
  • TBPH Health Care
  • Exchange
  • ZKH Nasdaq
  • TBPH Nasdaq
  • Market Cap
  • ZKH 588.1M
  • TBPH 485.8M
  • IPO Year
  • ZKH 2023
  • TBPH N/A
  • Fundamental
  • Price
  • ZKH $3.56
  • TBPH $8.58
  • Analyst Decision
  • ZKH Strong Buy
  • TBPH Buy
  • Analyst Count
  • ZKH 2
  • TBPH 4
  • Target Price
  • ZKH $12.65
  • TBPH $13.75
  • AVG Volume (30 Days)
  • ZKH 38.6K
  • TBPH 166.7K
  • Earning Date
  • ZKH 11-22-2024
  • TBPH 02-24-2025
  • Dividend Yield
  • ZKH N/A
  • TBPH N/A
  • EPS Growth
  • ZKH N/A
  • TBPH N/A
  • EPS
  • ZKH N/A
  • TBPH N/A
  • Revenue
  • ZKH $1,259,541,805.00
  • TBPH $63,192,000.00
  • Revenue This Year
  • ZKH $0.49
  • TBPH $11.41
  • Revenue Next Year
  • ZKH $12.88
  • TBPH $37.36
  • P/E Ratio
  • ZKH N/A
  • TBPH N/A
  • Revenue Growth
  • ZKH 3.49
  • TBPH 15.93
  • 52 Week Low
  • ZKH $2.62
  • TBPH $7.44
  • 52 Week High
  • ZKH $21.91
  • TBPH $10.44
  • Technical
  • Relative Strength Index (RSI)
  • ZKH 50.73
  • TBPH 33.59
  • Support Level
  • ZKH $3.50
  • TBPH $8.35
  • Resistance Level
  • ZKH $3.90
  • TBPH $8.86
  • Average True Range (ATR)
  • ZKH 0.24
  • TBPH 0.28
  • MACD
  • ZKH 0.01
  • TBPH -0.11
  • Stochastic Oscillator
  • ZKH 49.26
  • TBPH 14.74

About ZKH ZKH Group Limited each representing thirty-five (35)

ZKH Group Ltd engages in providing MRO procurement service platform in China. It provides one-stop MRO procurement and management services for its customers, and offers digital and fulfillment solutions for participants along the industry value chain. It offers a broad range of MRO product offerings covering all MRO product lines on its platform, including spare parts, chemicals, manufacturing parts, general consumables, and office supplies. All of the Group's revenues are derived from the PRC.

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to better meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

Share on Social Networks: